HomePUR • WSE
add
Pure Biologics SA
Previous close
zł 5.40
Day range
zł 3.72 - zł 4.50
Year range
zł 3.72 - zł 33.20
Market cap
16.54M PLN
Avg Volume
74.62K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 794.00K | -62.79% |
Net income | -1.34M | 73.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -765.00K | 63.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 227.00K | -95.71% |
Total assets | 2.33M | -88.15% |
Total liabilities | 15.78M | -30.56% |
Total equity | -13.45M | — |
Shares outstanding | 4.08M | — |
Price to book | -1.63 | — |
Return on assets | -85.63% | — |
Return on capital | -209.31% | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.34M | 73.08% |
Cash from operations | -785.00K | -133.53% |
Cash from investing | 21.00K | 290.91% |
Cash from financing | 677.00K | 204.64% |
Net change in cash | -86.00K | -105.11% |
Free cash flow | -707.88K | -115.40% |
About
Founded
2010
Website
Employees
7
